JP2007520566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520566A5 JP2007520566A5 JP2006552302A JP2006552302A JP2007520566A5 JP 2007520566 A5 JP2007520566 A5 JP 2007520566A5 JP 2006552302 A JP2006552302 A JP 2006552302A JP 2006552302 A JP2006552302 A JP 2006552302A JP 2007520566 A5 JP2007520566 A5 JP 2007520566A5
- Authority
- JP
- Japan
- Prior art keywords
- autoantigen
- antibody
- pharmaceutical composition
- antigen
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54195904P | 2004-02-04 | 2004-02-04 | |
| PCT/US2005/003712 WO2005076965A2 (en) | 2004-02-04 | 2005-02-04 | Anti-cd3 and antigen-specific immunotherapy to treat autoimmunity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007520566A JP2007520566A (ja) | 2007-07-26 |
| JP2007520566A5 true JP2007520566A5 (https=) | 2008-03-27 |
Family
ID=34860238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006552302A Pending JP2007520566A (ja) | 2004-02-04 | 2005-02-04 | 自己免疫治療のための抗ｃｄ３及び抗原特異的免疫療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070190045A1 (https=) |
| EP (1) | EP1725254A4 (https=) |
| JP (1) | JP2007520566A (https=) |
| AU (1) | AU2005213449A1 (https=) |
| CA (1) | CA2554978A1 (https=) |
| IL (1) | IL177193A0 (https=) |
| WO (1) | WO2005076965A2 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030108548A1 (en) * | 1993-06-01 | 2003-06-12 | Bluestone Jeffrey A. | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| AU2003300681A1 (en) * | 2002-10-02 | 2004-05-04 | Diamyd Medical Ab | Formulation of glutarmic acid decarboxylase (gad65) and serum albumin |
| CA2569509C (en) | 2004-06-03 | 2014-08-12 | Novimmune S.A. | Anti-cd3 antibodies and methods of use thereof |
| AU2006209837A1 (en) * | 2005-02-04 | 2006-08-10 | Dow Agrosciences, Llc | Anti-T cell and autoantigen treatment of autoimmune disease |
| WO2007009064A2 (en) * | 2005-07-11 | 2007-01-18 | Macrogenics, Inc. | Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| CN101309703A (zh) * | 2005-09-12 | 2008-11-19 | 诺维莫尼公司 | 抗cd3抗体组合物 |
| ES2405552T3 (es) | 2005-11-29 | 2013-05-31 | Actogenix N.V. | Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos |
| WO2007084775A2 (en) * | 2006-01-20 | 2007-07-26 | The Trustees Of The University Of Pennsylvania | Compositions and methods for modulation of suppressor t cell activation |
| EP2433650A3 (en) * | 2006-06-06 | 2012-12-19 | Tolerrx Inc. | Administration of anti-CD3 antibodies in the treatment of autoimmune diseases |
| SG177907A1 (en) | 2006-06-14 | 2012-02-28 | Macrogenics Inc | Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| CA2673470A1 (en) * | 2006-12-21 | 2008-07-03 | Macrogenics, Inc. | Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
| DE102007001370A1 (de) * | 2007-01-09 | 2008-07-10 | Curevac Gmbh | RNA-kodierte Antikörper |
| WO2008090223A2 (en) | 2007-01-25 | 2008-07-31 | Actogenix N.V. | Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus |
| CN101687019A (zh) * | 2007-04-24 | 2010-03-31 | 迪亚米德治疗股份公司 | 用于治疗自身免疫性疾病和癌症的药物和方法 |
| CA2778334A1 (en) * | 2009-10-20 | 2011-04-28 | Charlotte Mckee | Anti-cd3 antibody dosing in autoimmune disease |
| EP2525825A1 (en) * | 2010-01-20 | 2012-11-28 | Bayhill Therapeutics, Inc. | Combination therapy to treat autoimmune diseases |
| US9018006B2 (en) | 2010-07-23 | 2015-04-28 | The University Of Toledo | Stable Tregs and related materials and methods |
| CN106668852B (zh) * | 2012-04-13 | 2020-12-25 | 艾棣维欣(苏州)生物制药有限公司 | 一种治疗和/或预防ⅰ型糖尿病的组合物及其应用 |
| US8735359B2 (en) * | 2012-05-24 | 2014-05-27 | Orban Biotech Llc | Combinations of modalities for the treatment of diabetes |
| US12605432B2 (en) | 2014-06-04 | 2026-04-21 | Diamyd Medical Ab | Combinations for antigen based therapy |
| CN106535926B (zh) * | 2014-06-04 | 2022-02-01 | 戴尔米德医疗公司 | 用于基于抗原的疗法的新型组合物 |
| GB201510056D0 (en) * | 2015-06-10 | 2015-07-22 | King S College London | Multi-peptide composition |
| WO2018106945A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| WO2018183929A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| WO2019028503A1 (en) * | 2017-08-07 | 2019-02-14 | St Vincent's Institute Of Medical Research | THERAPY OF DIABETES TYPE 1 |
| WO2019246317A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease or condition in a tissue originating from the endoderm |
| WO2019246312A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| EP3883635A1 (en) | 2018-11-19 | 2021-09-29 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| CA3159054A1 (en) | 2019-12-06 | 2021-06-10 | Mary S. MORRIS | Methods and compositions for the treatment and prevention of type 1 diabetes |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| EP4493592A1 (en) | 2022-03-14 | 2025-01-22 | LamKap Bio gamma AG | Bispecific gpc3xcd28 and gpc3xcd3 antibodies and their combination for targeted killing of gpc3 positive malignant cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406696B1 (en) * | 1989-10-27 | 2002-06-18 | Tolerance Therapeutics, Inc. | Methods of stimulating the immune system with anti-CD3 antibodies |
| WO1991006319A1 (en) * | 1989-10-27 | 1991-05-16 | Arch Development Corporation | Methods and compositions for promoting immunopotentiation |
| US6150584A (en) * | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5770429A (en) * | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5885573A (en) * | 1993-06-01 | 1999-03-23 | Arch Development Corporation | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| US6491916B1 (en) * | 1994-06-01 | 2002-12-10 | Tolerance Therapeutics, Inc. | Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies |
| FR2730411B1 (fr) * | 1995-02-14 | 1997-03-28 | Centre Nat Rech Scient | Association medicamenteuse utile pour la transfection et l'expression in vivo d'exogenes |
| US5834597A (en) * | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
| US6420140B1 (en) * | 1996-10-11 | 2002-07-16 | Abgenix, Inc. | Production of multimeric protein by cell fusion method |
| US6884785B2 (en) * | 1999-06-17 | 2005-04-26 | The Scripps Research Institute | Compositions and methods for the treatment or prevention of autoimmune diabetes |
| US7378089B2 (en) * | 2001-10-02 | 2008-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Gene therapy for the prevention of autoimmune disease |
| US20040037826A1 (en) * | 2002-06-14 | 2004-02-26 | Michelsen Birgitte Koch | Combined use of a modulator of CD3 and a GLP-1 compound |
-
2005
- 2005-02-04 EP EP05722771A patent/EP1725254A4/en not_active Withdrawn
- 2005-02-04 JP JP2006552302A patent/JP2007520566A/ja active Pending
- 2005-02-04 WO PCT/US2005/003712 patent/WO2005076965A2/en not_active Ceased
- 2005-02-04 CA CA002554978A patent/CA2554978A1/en not_active Abandoned
- 2005-02-04 AU AU2005213449A patent/AU2005213449A1/en not_active Abandoned
-
2006
- 2006-08-01 IL IL177193A patent/IL177193A0/en unknown
- 2006-08-03 US US11/498,381 patent/US20070190045A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520566A5 (https=) | ||
| JP2005518433A5 (https=) | ||
| JP2007527914A5 (https=) | ||
| IL191117A (en) | Use of an anti-40 cd antibody in the preparation of a pharmaceutical preparation for the treatment of inflammatory or autoimmune disease and a preparation prepared therefor | |
| EA201100958A1 (ru) | Фармацевтическая пероральная дозированная лекарственная форма на основе ингибиторов dpp iv | |
| AR057807A1 (es) | Formulaciones de anticuerpo anti-cd3 | |
| EA201390450A1 (ru) | Полипептиды с увеличенной продолжительностью действия | |
| HRP20192295T1 (hr) | Optimizirana monoklonska protutijela protiv inhibitora faktora tkivnog puta (tfpi) | |
| IL197831A (en) | Human antibodies that bind 4cxcr, preparations containing them and their uses | |
| JP2009521520A5 (https=) | ||
| JP2007522094A5 (https=) | ||
| IL199216A (en) | Monoclonal Antibodies Against 3angptl, Pharmaceuticals Containing Them and Their Uses | |
| JP2009517473A5 (https=) | ||
| JP2007509067A5 (https=) | ||
| JP2012509886A5 (https=) | ||
| NO20083785L (no) | Funksjonelle antistoffer | |
| AR074777A1 (es) | Proteinas de union a antigeno | |
| IL178838A (en) | Antibodies that specifically bind to human p-psgl-1 and p-selectin, pharmacological preparations containing such antibody, and momentary acids and their encoded vectors | |
| IL209499A (en) | Human monoclonal antibody against influenza a virus, pharmaceutical compositions comprising the same and use thereof as medicaments | |
| JP2009505678A5 (https=) | ||
| JP2007517055A5 (https=) | ||
| WO2009114040A3 (en) | Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses | |
| WO2018116267A3 (en) | Methods of treatment with anti-factor xi/xia antibodies | |
| JP2011219478A5 (https=) | ||
| JP2011528897A5 (https=) |